Drug Shortage Report for KADIAN

Last updated on 2021-05-05 History
Report ID 138676
Drug Identification Number 02184435
Brand name KADIAN
Common or Proper name MORPHINE SULFATE
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 20MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BT
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-05-04
Actual start date
Estimated end date 2021-06-01
Actual end date
Shortage status Actual shortage
Updated date 2021-05-05
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-05-05 English Compare
v2 2021-05-04 French Compare
v1 2021-05-04 English Compare